145 related articles for article (PubMed ID: 28248066)
1. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
2. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
3. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer.
Lee HS; Lee HE; Park DJ; Kim HH; Kim WH; Park KU
Clin Chim Acta; 2012 Nov; 413(21-22):1753-60. PubMed ID: 22796372
[TBL] [Abstract][Full Text] [Related]
5. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.
Forget MA; Turcotte S; Beauseigle D; Godin-Ethier J; Pelletier S; Martin J; Tanguay S; Lapointe R
Br J Cancer; 2007 Feb; 96(4):646-53. PubMed ID: 17245340
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer.
Sheng SL; Huang G; Yu B; Qin WX
Clin Chem; 2009 Sep; 55(9):1656-64. PubMed ID: 19628661
[TBL] [Abstract][Full Text] [Related]
7. Assessing the diagnostic value of serum Dickkopf-related protein 1 levels in cancer detection: a case-control study and meta-analysis.
Jiang XT; Ma YY; Guo K; Xia YJ; Wang HJ; Li L; He XJ; Huang DS; Tao HQ
Asian Pac J Cancer Prev; 2014; 15(21):9077-83. PubMed ID: 25422182
[TBL] [Abstract][Full Text] [Related]
8. Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases.
Kasoha M; Bohle RM; Seibold A; Gerlinger C; Juhasz-Böss I; Solomayer EF
Clin Exp Metastasis; 2018 Dec; 35(8):763-775. PubMed ID: 30238177
[TBL] [Abstract][Full Text] [Related]
9. Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial.
Kim TH; Chang JS; Park KS; Park J; Kim N; Lee JI; Kong ID
PLoS One; 2017; 12(2):e0171771. PubMed ID: 28178355
[TBL] [Abstract][Full Text] [Related]
10. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and prognostic value of serum sHER-2/neu levels in patients with solid tumors.
Papila C; Uzun H; Balci H; Zerdali H; Sezgin C; Can G; Yanardag H
Med Oncol; 2009; 26(2):151-6. PubMed ID: 18855148
[TBL] [Abstract][Full Text] [Related]
12. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.
Igbinigie E; Guo F; Jiang SW; Kelley C; Li J
Clin Chim Acta; 2019 Jan; 488():226-234. PubMed ID: 30452897
[TBL] [Abstract][Full Text] [Related]
13. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.
Granchi D; Corrias MV; Garaventa A; Baglìo SR; Cangemi G; Carlini B; Paolucci P; Giunti A; Baldini N
Bone; 2011 Jan; 48(1):152-9. PubMed ID: 20603237
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma.
Tung EK; Mak CK; Fatima S; Lo RC; Zhao H; Zhang C; Dai H; Poon RT; Yuen MF; Lai CL; Li JJ; Luk JM; Ng IO
Liver Int; 2011 Nov; 31(10):1494-504. PubMed ID: 21955977
[TBL] [Abstract][Full Text] [Related]
16. Relationships among serum CA15-3 tumor marker, TNM staging, and estrogen and progesterone receptor expression in benign and malignant breast lesions.
Atoum M; Nimer N; Abdeldayem S; Nasr H
Asian Pac J Cancer Prev; 2012; 13(3):857-60. PubMed ID: 22631661
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.
Shukla S; Singh BK; Pathania OP; Jain M
Indian J Med Res; 2016 May; 143(Supplement):S52-S58. PubMed ID: 27748278
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma.
Fouad YM; Mohamed HI; Kamal EM; Rasek MA
Scand J Gastroenterol; 2016 Sep; 51(9):1133-7. PubMed ID: 27161933
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic potential of serum angiopoietin-2 expression in human breast cancer.
Li P; He Q; Luo C; Qian L
Int J Clin Exp Pathol; 2015; 8(1):660-4. PubMed ID: 25755760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
